Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clearmind Medicine Inc (NQ: CMND ) 1.350 -0.060 (-4.26%) Streaming Delayed Price Updated: 3:59 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Clearmind Medicine Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures November 27, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket November 27, 2023 Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter. Via Benzinga Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice November 21, 2023 Clearmind Medicine Inc. (NASDAQ: CMND) is set to conduct a 1-for-30 reverse share split of its issued and outstanding ordin Via Benzinga Clearmind Medicine Announces 1-for-30 Reverse Share Split November 21, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance November 17, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Announces Shareholders Meeting Results November 15, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities November 09, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 12, 2023 Gainers Via Benzinga Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket October 12, 2023 Gainers OpGen, Inc. (NASDAQ: OPGN) shares rose 432% to $1.79 in pre-market trading. Opgen said on Oct. 6, unit Curetis GMBH received payment of 750,000 euros related to the sale of certain Unyvero A50... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday October 12, 2023 Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning! Via InvestorPlace Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session October 11, 2023 Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... Via Benzinga Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th October 05, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise September 20, 2023 EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Intellectual Property Exposures Death Intellectual Property Aegis Capital Corp. Acted as Exclusive Placement Agent on a $2.25 Million Public Offering for Clearmind Medicine Inc. (NASDAQ:CMND) September 19, 2023 Via ACCESSWIRE Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More September 18, 2023 Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next Via Benzinga Exposures Product Safety Clearmind Medicine Closes US$2.25 Million Public Offering September 18, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering September 15, 2023 Beckley Waves: $3.3 Million Round To Expand Safe & Legal Access To Psychedelic Therapies Via Benzinga Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher September 14, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.93% to 34,898.47 while the NASDAQ rose 0.75% to 13,917.44.... Via Benzinga Topics Stocks Exposures US Equities Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 14, 2023 Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi. Via Benzinga Crude Oil Rises Sharply; BIOLASE Shares Plunge September 14, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Clearmind Medicine Stock Is Getting Hammered Today September 14, 2023 Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 53% to $0.18 Thursday morning after the company announced pricing of a $2.25 million public offering. The offering is expected to close... Via Benzinga Dow Jumps Over 200 Points; US Producer Prices Rise In August September 14, 2023 U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.71% to 34,820.58 while the NASDAQ rose 0.27% to 13,849.49. The S&P... Via Benzinga Topics Stocks Exposures US Equities Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering September 14, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket September 14, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 43.3% to $1.29 in pre-market trading. Via Benzinga Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Nasdaq Grants SpiSparc, Ltd. Extension To Maintain Listing: +600% Bid Price Surge Needed September 07, 2023 Specialty clinical-stage biopharma company SciSparc Ltd. (NASDAQ: SPRC) has received a Nasdaq notice granting the company an additional 180-day compliance period until March 4 to regain compliance with... Via Benzinga Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program September 06, 2023 Israeli psychedelics biotech Clearmind Medicine (NASDAQ: CMND) has inked a research agreement with Johns Hopkins University School of Medicine (JHU) to conduct the first-in-human Phase I/IIa clinical... Via Benzinga Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder September 06, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company August 14, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio August 01, 2023 From Clearmind Medicine Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
